SMARCA4 is a well-known gene associated with CAD, and it mediated nucleosome remodeling which was considered another epigenetic mechanism that can affect the course of COVID-19 (Peng et al., 2020; Shirvaliloo, 2021). The gene discussed is SMARCA4; the disease is coronary artery disorder.